<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21010">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02833376</url>
  </required_header>
  <id_info>
    <org_study_id>MPLCT</org_study_id>
    <nct_id>NCT02833376</nct_id>
  </id_info>
  <brief_title>Alcohol 70% Versus Chlorhexidine 0.5% in the Spinal Anesthesia Skin Antissepsis</brief_title>
  <official_title>Alcohol 70% Versus Chlorhexidine 0.5% in the Spinal Anesthesia Skin Antissepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade do Vale do Sapucai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade do Vale do Sapucai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Context: The neuraxial blocks, spinal anesthesia and epidural anesthesia are among the most
      frequently performed procedures worldwide, and despite the advancements of medical
      equipment, remain dependent on experience and practice of the anesthesiologists. Although
      antisepsis takes part of the daily routine, there are still no solid scientific evidence of
      the most appropriate antiseptic for these procedures.

      Objective: To compare the 70% alcohol and 0.5% chlorhexidine alcohol solution in skin
      antisepsis for the neuraxial blocks.

      Methods: This is a clinical trial, a prospective, randomized study. There will be selected,
      consecutively, 70 patients candidates for neuraxial blocks. Patients will be randomly
      assigned to group A (n = 35), in which the antisepsis will be performed with alcohol 70%,
      and to group B (n = 35), in which the antiseptic will be performed with the 0.5%
      chlorhexidine in alcoholic solution. Samples will be collected with swabs in an area of 25
      cm² for bacterial cultures three times: in pre-antisepsis moments, in the second minute
      after antisepsis, and immediately after the puncture. The number of colonies forming units
      per square centimeter (CFU / cm²) will be counted. The data will be analyzed statistically.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin colonization before and after antisepsis, Will be counted number of colonies forming units per square centimeter (CFU/cm²)</measure>
    <time_frame>Before antisepsis</time_frame>
    <description>The material will be collected in a pre determined field of 25 cm², with a swab, and the maximum seeding in 8 hours, 48 hours after will be counted the number of colonies forming units per square centimeter (CFU/cm²)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin colonization before and after antisepsis, Will be counted number of colonies forming units per square centimeter (CFU/cm²)</measure>
    <time_frame>2 minutes after antisepsis</time_frame>
    <description>The material will be collected in a pre determined field of 25 cm², with a swab, and the maximum seeding in 8 hours, 48 hours after will be counted the number of colonies forming units per square centimeter (CFU/cm²)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin colonization before and after antisepsis, Will be counted number of colonies forming units per square centimeter (CFU/cm²)</measure>
    <time_frame>After the Puncture and at most 40 minutes</time_frame>
    <description>The material will be collected in a pre determined field of 25 cm², with a swab, and the maximum seeding in 8 hours, 48 hours after will be counted the number of colonies forming units per square centimeter (CFU/cm²)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Anesthesia, Spinal</condition>
  <condition>Anesthesia, Epidural</condition>
  <condition>Antisepsis</condition>
  <arm_group>
    <arm_group_label>Alcohol group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients allocated to this group will receive skin antisepsis with alcohol 70% prior spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chlorhexidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients allocated to this group will receive skin antisepsis with alcoholic solution of chlorhexidine 0.5% prior spinal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>alcohol antisepsis</intervention_name>
    <arm_group_label>Alcohol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>chlorhexidine antisepsis</intervention_name>
    <arm_group_label>Chlorhexidine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 18 and 65 years of age , without restriction as to sex, ethnicity,
             education or social class;

          -  Patients who are undergoing neuraxial blockade by indicating the anesthesiologist
             responsible for the procedure

        Exclusion Criteria:

          -  comorbidities or conditions which constitute a contraindication for the neuroaxial
             block ;

          -  Body mass index (BMI ) greater than 30 kg / m2;

          -  Ongoing infection;

          -  Use of antibiotics in the last seven days;

          -  Skin lesions at the puncture site ;

          -  Refusal to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniela F Veiga, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Universidade do Vale do Sapucai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana Beatriz A Loyola, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidade do Vale do Sapucai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luiz C Tostes, MD</last_name>
    <phone>55-38-999707009</phone>
    <email>lctostes@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital e Maternidade Santa Paula</name>
      <address>
        <city>Pouso Alegre</city>
        <state>Minas Gerais</state>
        <zip>37550-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luiz C Tostes, MD</last_name>
      <phone>55-38-999707009</phone>
      <email>lctostes@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 13, 2016</lastchanged_date>
  <firstreceived_date>July 5, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade do Vale do Sapucai</investigator_affiliation>
    <investigator_full_name>Luiz Carlos Tostes</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>microbiota</keyword>
  <keyword>ethanol</keyword>
  <keyword>chlorhexidine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
